A new report from Pharmaceutical Strategies Group finds that specialty drugs continue to be a top focus for plan sponsors, in part because they tend to be very expensive.

California has gone through more lulls and surges than we can count at this point, but it looks like we’re heading for another uptick. The Omicron variant has evolved into more subvariants, doctors are masking up again and California has seen a 50 percent increase in cases over the past two weeks.

Alphabet Inc.’s Google will provide any U.S. business over $100,000 worth of online courses in data analytics, design and other tech skills for their workers free of charge, the search company said on Monday.

Bryan Ruiz moved his family into a newly built home in this Central Valley farming center seven months ago and almost immediately found they were under assault. Mosquitoes bit and harassed them in broad daylight. He looked around, trying to find a water source where they were breeding, and noticed a freshly dug pipe, meant ...

Covid cases surged during the last two winters and are likely to again this year — unless the country can prepare and act, White House Covid-19 response coordinator Ashish Jha said Sunday morning. “If we don’t get ahead of this thing, we’ll have a lot of waning immunity, this virus continues to evolve and we ...

Prescription drug rebates from drugmakers to commercial health plans are steadily increasing, a study published in JAMA Health Forum shows. Why it matters: This is all part of a system in which drugmakers negotiate to get their product on the formularies of middlemen known as pharmacy benefit managers and health plans. * “While drug rebates can reduce plans’ net costs, ...